Two Different Serum-free Media and Osmolality Effect Upon Human 293 Cell Growth and Adenovirus Production

[1]  P. Alves,et al.  Use of adenoviral vectors as veterinary vaccines , 2005, Gene Therapy.

[2]  P. Alves,et al.  Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities. , 2005, Journal of biotechnology.

[3]  Amine Kamen,et al.  Development and optimization of an adenovirus production process , 2004, The journal of gene medicine.

[4]  D. Vacante,et al.  Comparison of manufacturing techniques for adenovirus production , 1999, Cytotechnology.

[5]  A. Kamen,et al.  Production of adenovirus vector for gene therapy. , 2003, Biotechnology advances.

[6]  A. Garnier,et al.  pH, pCO2, and Temperature Effect on R‐Adenovirus Production , 2003, Biotechnology progress.

[7]  A. Mountain,et al.  Gene therapy: the first decade. , 2000, Trends in biotechnology.

[8]  R. Offringa,et al.  Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing Subset , 1999, Journal of Virology.

[9]  A. Kamen,et al.  Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. , 1998, Biotechnology and bioengineering.

[10]  J. Spaltro,et al.  Virus assay methods: accuracy and validation. , 1998, Biologicals : journal of the International Association of Biological Standardization.

[11]  A. Kamen,et al.  Study of Adenovirus Production in Serum‐Free 293SF Suspension Culture by GFP‐Expression Monitoring , 1997, Biotechnology progress.

[12]  C. Chavarie,et al.  Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies. , 2000, Biotechnology and bioengineering.

[13]  M. Eloit,et al.  Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species. , 1995, The Journal of general virology.